GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GAP43 | Growth associated protein 43 | Plasma proteins Transporters
| | | | | Tissue enriched |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GLE1 | GLE1 RNA export mediator | Disease related genes Potential drug targets Transporters
| | | | | Expressed in all |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
GNLY | Granulysin | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GRIA2 | Glutamate receptor, ionotropic, AMPA 2 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
GRM1 | Glutamate receptor, metabotropic 1 | Disease related genes G-protein coupled receptors Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
HSPA1A | Heat shock 70kDa protein 1A | Cancer-related genes Mitochondrial proteins Plasma proteins Transporters
| | | | | Expressed in all |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HVCN1 | Hydrogen voltage-gated channel 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ITPR1 | Inositol 1,4,5-trisphosphate receptor, type 1 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Transporters
| | | | | Tissue enhanced |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNF1 | Potassium voltage-gated channel, subfamily F, member 1 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
KCNIP4 | Kv channel interacting protein 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNK5 | Potassium channel, subfamily K, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Mixed |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
LAMP1 | Lysosomal-associated membrane protein 1 | CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
LETM1 | Leucine zipper-EF-hand containing transmembrane protein 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MAGOH | Mago-nashi homolog, proliferation-associated (Drosophila) | Transporters
| | | | | Expressed in all |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MT-CO1 | Mitochondrially encoded cytochrome c oxidase I | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
MT-CO2 | Mitochondrially encoded cytochrome c oxidase II | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
MTCH1 | Mitochondrial carrier 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
NCBP1 | Nuclear cap binding protein subunit 1, 80kDa | Transporters
| | | | | Expressed in all |
NCBP2 | Nuclear cap binding protein subunit 2, 20kDa | Transporters
| | | | | Expressed in all |
NOX1 | NADPH oxidase 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
NPLOC4 | Nuclear protein localization 4 homolog (S. cerevisiae) | Transporters
| | | | | Expressed in all |
NSF | N-ethylmaleimide-sensitive factor | Enzymes Transporters
| | | | | Tissue enriched |
NXF1 | Nuclear RNA export factor 1 | Transporters
| | | | | Expressed in all |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
OPA1 | Optic atrophy 1 (autosomal dominant) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Transporters
| | | | | Expressed in all |
P2RX4 | Purinergic receptor P2X, ligand-gated ion channel, 4 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
PEX13 | Peroxisomal biogenesis factor 13 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PEX14 | Peroxisomal biogenesis factor 14 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PEX19 | Peroxisomal biogenesis factor 19 | Disease related genes Potential drug targets Transporters
| | | | | Expressed in all |
PEX2 | Peroxisomal biogenesis factor 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PEX26 | Peroxisomal biogenesis factor 26 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PEX3 | Peroxisomal biogenesis factor 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PEX6 | Peroxisomal biogenesis factor 6 | Disease related genes Potential drug targets Transporters
| | | | | Expressed in all |
PLN | Phospholamban | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |